PhD
Assistant Professor, Pharmacology
UNC-Chapel Hill
Molecular Therapeutics
Area of Interest
The Palmer Laboratory investigates combinations of cancer therapies: understanding the mechanisms of successful drug combinations, to inform the development of combinations with new cancer therapies. Our approach is a synthesis of experimental studies, computational analysis of clinical data, and mathematical modeling.
I have a particular interest in the clinical implications of variation in drug response between patients and between cells (a consequence of inter-tumor and intra-tumor heterogeneity). Because heterogeneity is a universal feature of cancers and their responses to therapy, this research impacts our understanding of treatment success and failure across many forms of cancer and types of therapies.
Our experimental focus is on curative combination therapies for aggressive lymphomas; many new therapies have been developed for these diseases, and we are taking a systematic approach to find optimal drug combinations for different patient subsets. The basic and translational research we are pursuing serves the practical goal of improving the design of drug combinations and the interpretation of clinical trials that test them.
News and Stories
UNC researchers to present at American Society of Clinical Oncology annual meeting
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
